Cargando…
Probiotic-Induced Tolerogenic Dendritic Cells: A Novel Therapy for Inflammatory Bowel Disease?
Inflammatory bowel diseases (IBDs) are immune-mediated, chronic relapsing diseases with a rising prevalence worldwide in both adult and pediatric populations. Treatment options for immune-mediated diseases, including IBDs, are traditional steroids, immunomodulators, and biologics, none of which are...
Autores principales: | Baradaran Ghavami, Shaghayegh, Asadzadeh Aghdaei, Hamid, Sorrentino, Dario, Shahrokh, Shabnam, Farmani, Maryam, Ashrafian, Fatemeh, Dore, Maria Pina, Keshavarz Azizi Raftar, Shahrbanoo, Mobin Khoramjoo, Seyed, Zali, Mohammad Reza |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8348973/ https://www.ncbi.nlm.nih.gov/pubmed/34361038 http://dx.doi.org/10.3390/ijms22158274 |
Ejemplares similares
-
Immunomodulation and Generation of Tolerogenic Dendritic Cells by Probiotic Bacteria in Patients with Inflammatory Bowel Disease
por: Ghavami, Shaghayegh Baradaran, et al.
Publicado: (2020) -
Overview of Three Proliferation Pathways (Wnt, Notch, and Hippo) in Intestine and Immune System and Their Role in Inflammatory Bowel Diseases (IBDs)
por: Khoramjoo, Seyed Mobin, et al.
Publicado: (2022) -
Serological response to SARS‐CoV‐2 is attenuated in patients with inflammatory bowel disease and can affect immunization
por: Ghavami, Shaghayegh Baradaran, et al.
Publicado: (2022) -
Selective serotonin reuptake inhibitors and inflammatory bowel disease; Beneficial or malpractice
por: Hatamnejad, Mohammad Reza, et al.
Publicado: (2022) -
Detection of SARS-CoV-2 Genome in Stool and Plasma Samples of Laboratory Confirmed Iranian COVID-19 Patients
por: Makhmalbaf, Mobin, et al.
Publicado: (2022)